Jane Street’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7K Sell
23,755
-100,313
-81% -$105K ﹤0.01% 11182
2025
Q4
$140K Buy
+124,068
New +$174K ﹤0.01% 9980
2021
Q4
Sell
-21,212
Closed -$98K 10593
2021
Q3
$98K Buy
+21,212
New +$88.4K ﹤0.01% 9308
2020
Q4
Sell
-15,196
Closed -$58K 7900
2020
Q3
$58K Buy
+15,196
New +$83.3K ﹤0.01% 6888
2014
Q3
Sell
-1,463
Closed -$124K 2893
2014
Q2
$124K Sell
1,463
-2,008
-58% -$143K ﹤0.01% 2326
2014
Q1
$223K Buy
+3,471
New +$297K ﹤0.01% 2265

Other funds holding NNVC

Jane Street's NNVC Position: Q1 2026 in Review

Jane Street reduced its NanoViricides (NNVC) stake by 81% in Q1 2026, selling an estimated $105K and leaving 23,755 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #11182.

Jane Street first reported a position in NNVC in Q1 2014 and has held it in 6 quarters since. The position peaked at $223K in Q1 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q1 2026.

  • Jane Street held 23,755 shares of NanoViricides worth $21.7K as of Q1 2026.
  • Jane Street sold 100,313 NanoViricides shares in Q1 2026, an estimated $105K.
  • NanoViricides made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11182 holding.
  • Jane Street first reported a position in NanoViricides in Q1 2014 and has held it in 6 quarters since.
  • Jane Street's NanoViricides position peaked at $223K in Q1 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.